Your browser doesn't support javascript.
loading
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
Borchmann, Peter; Haverkamp, Heinz; Lohri, Andreas; Mey, Ulrich; Kreissl, Stefanie; Greil, Richard; Markova, Jana; Feuring-Buske, Michaela; Meissner, Julia; Dührsen, Ulrich; Ostermann, Helmut; Keller, Ulrich; Maschmeyer, Georg; Kuhnert, Georg; Dietlein, Markus; Kobe, Carsten; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Diehl, Volker; Engert, Andreas.
Afiliación
  • Borchmann P; Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany. Electronic address: peter.borchmann@uni-koeln.de.
  • Haverkamp H; Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany.
  • Lohri A; Cantonal Hospital Baselland, Liestal, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Mey U; Cantonal Hospital Graubuenden, Chur, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Kreissl S; Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, Cologne, Germany.
  • Greil R; Third Medical Department, Paracelcus Medical University, Salzburg, Austria.
  • Markova J; University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Feuring-Buske M; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Meissner J; University Hospital of Heidelberg, Heidelberg, Germany.
  • Dührsen U; Department of Hematology, University Hospital of Essen, Essen, Germany.
  • Ostermann H; Department of Internal Medicine III, Klinikum Großhadern, Munich, Germany.
  • Keller U; Department of Internal Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
  • Maschmeyer G; Department of Internal Medicine, Haematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Germany.
  • Kuhnert G; Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany.
  • Dietlein M; Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany.
  • Kobe C; Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany.
  • Eich H; Department of Radiotherapy, University Hospital of Muenster, Muenster, Germany.
  • Baues C; Department of Radiotherapy, University Hospital of Cologne, Cologne, Germany.
  • Stein H; Berlin Reference Center for Lymphoma and Haematopathology, Berlin, Germany.
  • Fuchs M; Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, Cologne, Germany.
  • Diehl V; German Hodgkin Study Group, Cologne, Germany.
  • Engert A; Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, Cologne, Germany.
Lancet Oncol ; 18(4): 454-463, 2017 04.
Article en En | MEDLINE | ID: mdl-28236583
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Tomografía de Emisión de Positrones / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Tomografía de Emisión de Positrones / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article